This document is a publication of a European patent application (EP4709388A1) by Otsuka Pharmaceutical Co., Ltd., titled 'Inhibitor of megakaryocyte differentiation and maturation'. The publication date is March 18, 2026. The application includes IPC classifications related to pharmaceutical preparations and treatments for blood disorders.

As this is a patent publication, it does not impose direct regulatory obligations or compliance deadlines on companies. However, it signifies potential future developments in drug discovery and intellectual property within the pharmaceutical sector. Companies involved in related research or development may wish to monitor this patent's progress and consider its implications for their own IP strategies.